Rheumatology

Latest News

Using Telemedicine Interventions During COVID-19 to Expand Care Post COVID-19

January 24th 2023

The Patient-Centered Rheumatology Collaborative identified several critical areas for further intervention to improve the delivery of high-quality, patient-centered care during the COVID-19 pandemic and beyond.

A graphic with the title and health icons
Top 5 Most-Read Rheumatology Articles of 2022

January 1st 2023

picture of cannabis leaf
Cannabis Improves Quality of Life in Women With Treatment-Resistant Fibromyalgia

December 14th 2022

graphic depicting immune system
Stopping Methotrexate for 1 Week After Flu Vaccine May Work as Well as 2 Weeks

December 1st 2022

Cardiac
Early TNF Inhibitor Initiation in Ankylosing Spondylitis Linked to Increased Cardiovascular Risk

November 15th 2022

More News

doctor and patient
February 23rd 2022

Analysis Identifies Predictors of Disease Flare for Patients With RA in Remission

Hayden E. Klein
Defined cut-off scores for patient function and MRI-detected bone erosion may potentially help clinicians and patients with rheumatoid arthritis (RA) in remission decide when to stop treatment.
person filling out survey on tablet
February 17th 2022

Researchers Develop Patient‐Perceived Methotrexate Intolerance Scale for Patients With RA

Hayden E. Klein
According to the authors, this is the first study to approach methotrexate intolerance measurement from a patient perspective.
vaccine
February 9th 2022

Updates to American College of Rheumatology's COVID-19 Vaccine Guidelines for RMD

Hayden E. Klein
Version 5 of “COVID-19 Vaccine Clinical Guidance Summary for Patients with Rheumatic and Musculoskeletal Diseases" includes updated recommendations that differentiate supplemental and booster doses for people with rheumatic and musculoskeletal diseases (RMDs).
white pills
February 4th 2022

Use of Multiple Targeted Therapies for RA Linked to Herpes Zoster Risk, Study Finds

Hayden E. Klein
Patients with rheumatoid arthritis (RA) who used 3 or more targeted therapies, but not Janus kinase inhibitors, were at greater risk of developing herpes zoster, according to findings from a Korean study.
doctor coat
January 30th 2022

Secukinumab Successfully Treats AGEP in Case Study

Rose McNulty
A patient with medication-induced severe acute generalized exanthematous pustulosis responded to treatment with secukinumab after unsuccessful courses of topical and systemic steroids.
Doctor giving vaccine
January 28th 2022

Decreasing COVID-19 Antibody Levels Among Patients With Rheumatic, Musculoskeletal Disease

Hayden E. Klein
A study found that antibody response against COVID-19 decreased by 2.8 times between months 1 and 6 post vaccination among people with rheumatic and musculoskeletal disease.
Pills.
January 28th 2022

Combination Therapy May Prevent Secukinumab Switching in Psoriasis

Matthew Gavidia
Patients with psoriasis who experienced secukinumab secondary failure did not require switching after experiencing significant improvement of daily functioning and quality of life when given a combination rescue therapy.
Blood test
January 25th 2022

Refining Serological Weight Scoring to Increase RA Classification Specificity

Hayden E. Klein
After analyzing past studies and classification criteria, authors found multiple factors that could be implemented into the current rheumatoid factor (RF) and anti-citrullinated protein antibodies (ACPA) tests for a more specific rheumatoid arthritis (RA) classification.
woman with hypothyroidism
January 24th 2022

Older Women With RA at Higher Risk of Developing Hypothyroidism

Hayden E. Klein
Women in the study were 3 times more likely to be affected by rheumatoid arthritis (RA) and nearly 4 times more likely to develop hypothyroidism, compared with men.
younger person holding hands with older person
January 14th 2022

Frailty Lowers Likelihood of Achieving Comprehensive Disease Control in RA, Study Finds

Hayden E. Klein
A study found that frailty reduced the likelihood of comprehensive disease control achievement by patients with rheumatoid arthritis (RA) being treated with a biologic agent.
person receiving vaccine
January 12th 2022

Study Finds No Link Between Adalimumab, Secukinumab and COVID-19 Vaccine Immune Response

Hayden E. Klein
Neither adalimumab nor secukinumab substantially affected a patient’s immune response to the Pfizer COVID-19 vaccine.
Nurse after receiving vaccine
January 7th 2022

COVAX Data Show Similar COVID-19 Vaccine Safety Between General Public, Patients With RMD

Hayden E. Klein
The safety profiles of COVID-19 vaccines in patients with inflammatory rheumatic and musculoskeletal disease (RMD) was comparable with patients with non-inflammatory RMD and the general population, according to a new study.
Doctor in lab
January 6th 2022

Research Finds MRP8/14 May Be a Biomarker of Systemic Juvenile Idiopathic Arthritis

Hayden E. Klein
Investigation into myeloid-related protein 8/14 (MRP8/14) serves as an important next step of translational research to discovering a diagnostic biomarker for systemic juvenile idiopathic arthritis.
Top 5 most read rheumatology articles of 2021
December 26th 2021

Top 5 Most-Read Rheumatology Content of 2021

Laura Joszt, MA
Readers were most interested in articles about cost of therapy, drug efficacy, and a unique case related to COVID-19.
RA and High Sodium Intake Are Associated With Increased Risk of MACE in Korean Population
December 24th 2021

RA and High Sodium Intake Are Associated With Increased Risk of MACE in Korean Population

Laura Joszt, MA
A study of the adult Korean population found high salt intake was associated with an increase in major adverse cardiovascular events (MACE) in patients with rheumatoid arthritis (RA).
FDA logo
December 23rd 2021

Secukinumab Approved for Pediatric Patients With ERA, PsA

Gianna Melillo
Secukinumab is approved for use among patients with enthesitis-related arthritis (ERA) aged 4 years and up, and those with psoriatic arthritis (PsA) who are at least 2 years old.
In Evaluating Rheumatoid Arthritis Treatments, Involving Patients Is Key
December 17th 2021

In Evaluating Rheumatoid Arthritis Treatments, Involving Patients Is Key

Stacy Courtnay
Stacy Courtnay is the community network chair for the Arthritis Foundation in Atlanta highlights a report that discusses how understanding patient experiences in RA can shift questions researchers ask.
Child receiving subcutaneous medication
December 15th 2021

Review Explains Value of Secukinumab for Children, Adolescents With Moderate to Severe Plaque Psoriasis

Hayden E. Klein
With a low number of approved medications for pediatric plaque psoriasis, secukinumab is a valuable new addition to the limited treatment options available.
Woman with arthritis holding hand
December 10th 2021

Switching From TNFi to Non-TNFi Linked With Sustained Clinical Response in Patients With RA

Hayden E. Klein
Study investigators saw sustained clinical response regardless of whether the participant with rheumatoid arthritis (RA) had discontinued the first tumor necrosis factor inhibitor (TNFi) due to a primary or secondary inefficacy.
Yoga class
December 8th 2021

Study Finds Decreased Exercise, Increased Body Weight in Individuals With RA During COVID-19 Lockdown

Hayden E. Klein
Limited access to exercise equipment and facilities during lockdown appears to be a key reason for reduced physical activity levels.
Long-term Mortality Decline in RA Skips Those Who Also Have Interstitial Lung Disease
December 4th 2021

Long-term Mortality Decline in RA Skips Those Who Also Have Interstitial Lung Disease

Mary Caffrey
Interstitial lung disease (ILD), created by inflammation that leads to scarring of the lungs, causes shortness of breath, dry cough, and fatigue; data show it doubles mortality risk in rheumatoid arthritis (RA).
arthritis
December 3rd 2021

Review Explains Role of IL-11 in Inflammatory Diseases

Hayden E. Klein
Circulating Interleukin-11 is difficult to detect in healthy individuals, but when it is present in various inflammatory diseases, it has an elevated present in affected tissues, according to a literature review.
arthritis
November 23rd 2021

Study Finds Link Between Ultrasounds, PROs in Patients With RA, Low Disease Activity

Hayden E. Klein
New research found that residual inflammation in ultrasound images was associated with patient-reported outcomes (PROs) in patients with rheumatoid arthritis (RA) with low disease activity, but not in patients in remission.
almonds
November 21st 2021

Anti-inflammatory Diet May Affect Physical Functioning in RA

Jared Kaltwasser
A new sub-analysis suggested eating foods with anti-inflammatory properties may improve physical functioning in patients with rheumatoid arthritis.
man holding his knee, which shows an xray image of his bones
November 20th 2021

Studies Ask if Gender Has an Effect on Secukinumab Efficacy in AS and PsA

Skylar Jeremias
Abstracts from American College of Rheumatology Convergence 2021 showed whether gender can impact the effectiveness of secukinumab in patients with ankylosing spondylitis (AS) or psoriatic arthritis (PsA).
covid-19 graphic
November 17th 2021

Abstracts Detail COVID-19 Breakthrough Infection, Long Haul Prevalence in Rheumatic Disease

Gianna Melillo
Data outline prevalence of COVID-19 breakthrough and long haul infections among patients with rheumatic diseases.
Doctor filling out form
November 12th 2021

Research Identifies Potentially Predictive Factors of Rheumatoid Arthritis Disease Course

Hayden E. Klein
Biological markers collected early in the disease course of rheumatoid arthritis could help improve patient management, researchers said.
Group of children
November 10th 2021

JUNIPERA Shows Consistent Improvement, Longer Time to Flare for Secukinumab in Children and Adolescents

Hayden E. Klein
If FDA approved for children, secukinumab (Cosentyx) will be the first biologic treatment for children in the US living with enthesitis-related arthritis.
Doctor using telephone
November 4th 2021

Study Reveals Impact of COVID-19 on Inflammatory Arthritis Management

Hayden E. Klein
The most common health care disruption found in the study was the replacement of face-to-face consultations with over-the-phone appointments.
Clinical Trials Link Systemic Inflammatory Disorders to Cardiovascular Disease Risk
November 1st 2021

Clinical Trials Link Systemic Inflammatory Disorders to Cardiovascular Disease Risk

Hayden E. Klein
The review found an association between systemic inflammatory disorders and increased risk of cardiovascular disease, encouraging discussions with patients regarding statin therapy.
<12345678
...
11>

2 Commerce Drive
Suite 100
Cranbury, NJ 08512

© 2024 MJH Life Sciences® and AJMC®.
All rights reserved.

About
Contact
Editorial Boards
Advertise
Do Not Sell My Information
Terms & Conditions
Privacy Policy
AJMC Managed Markets Network Logo
CH LogoCenter for Biosimilars Logo